share_log

Ginkgo Bioworks | 4: Statement of changes in beneficial ownership of securities-Director DEKKERS MARIJN E

SEC announcement ·  May 15 05:16
Summary by Futu AI
Marijn E. Dekkers, associated with Ginkgo Bioworks Holdings, Inc. [DNA], has initiated a sale of 1,727,056 shares of Class A Common Stock on May 14, 2024. The shares were sold at a price of $0.93 each, resulting in a total transaction value of $1,606,162.08. Following the transaction, Dekkers directly holds 281,217 shares. The sale is currently in progress. Additionally, Dekkers has an indirect beneficial ownership of 5,780,364 shares through Novalis LifeSciences Investments I, L.P.
Marijn E. Dekkers, associated with Ginkgo Bioworks Holdings, Inc. [DNA], has initiated a sale of 1,727,056 shares of Class A Common Stock on May 14, 2024. The shares were sold at a price of $0.93 each, resulting in a total transaction value of $1,606,162.08. Following the transaction, Dekkers directly holds 281,217 shares. The sale is currently in progress. Additionally, Dekkers has an indirect beneficial ownership of 5,780,364 shares through Novalis LifeSciences Investments I, L.P.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.